CBA-539 Injection
The 2030 global medical aesthetic market
US$306BThe 2030 global Anti-aging market
US$116B- CBA-539 can inhibit melanin production and transmission, reduce spots, and even skin tone.
- It can promote autologous collagen proliferation and increase skin elasticity and firmness.
- With no recovery time, no sequelae and no postoperative care, it can avoid troubles of current laser treatments.
- It is a non-filling agent, with natural outcome, without causing facial expression stiffness or nodules.
- 6~12 months of curative effect can be reached by 2-3 treatments.
Indications
- Hyperpigmentation, Skin Aging
Stage
Hyperpigmentation, Skin Aging
Market Overview
According to the Deloitte China Medical Beauty Market Trend Insights report, the global medical beauty market reached US$145.9 billion in 2019 with a CAGR of 7%. It is estimated at US$306.2 billion in 2030. According to the Statista market report, the global anti-aging market was estimated at US$58.5 billion in 2020, and is expected to reach US$116.2 billion in 2030. According to the current analysis of Reports and Data, the global Pigmentation Disorders Treatment Market valued at USD 5.35 billion in 2018 and is expected to reach USD 11 billion by the year 2027, at a CAGR of 8.4%.
Introduction to Hyperpigmentation & Skin Aging
The increase of age leads to various problems, including collagen loss, wrinkles, loss of subcutaneous fat, etc. With the increase of the global population aging, coupled with the increasing awareness of beauty and maintenance, the market demand for anti-aging is driven. And with technological advancement in medical aesthetic, various anti-aging medical aesthetic products have been developed, such as botulinum injections, hyaluronic acid injections, filler injections, to reduce wrinkles and smooth skin.
The ingredients of common anti-aging injections in the market include hyaluronic acid, fillers, botulinum and microcrystalline porcelain. However, the effect can only be maintained for a few months, while frequent injections may cause unnatural facial expressions or result in obvious swelling and nodules. Thus, the development of anti-aging products that promote collagen proliferation naturally will be the future market trend.)
In Asia, white skin is considered as an indispensable sign of beauty for women, while lightening blemishes is more the concern among European and American women. Thus, skin whitening and lightening products grow in global market.
Currently, laser is the main treatment to whiten skin and lighten spots. However, it requires multiple treatments and postoperative wound care, and it may cause infection or inflammation. Therefore, to develop products with high efficacy and low side effects will be the trend of the future market.
R & D Progress
CBA-539 is a long-acting sustained-release injection, which can inhibit the production and transmission of melanin, reduce spots, and promote the proliferation of autologous collagen to achieve the anti-aging effect of increasing skin elasticity. The product is currently in the preclinical stage.